|
 
ProNAi Therapeutics, Inc. is a privately held biopharmaceutical company. To date, the company has raised $15 million in equity and convertible notes.
ProNAi’s institutional investors include:
- Apjohn Ventures, Kalamazoo, MI
- Grand Angels, Grand Rapids, MI
- Michigan Strategic Fund/MEDC
- Biosciences Research Commercialization Center, Kalamazoo, MI
- Sigvion Ventures, Chicago, IL
- Amherst Fund, Ann Arbor, MI
- BlueWater Angels, Midland, MI
|
